Teva Pharmaceuticals USA, INC.
Pharmaceutical manufacturer
Based in NJ
🤖
AI Overview
With $610K in lobbying spend across 10 quarterly filings, Teva Pharmaceuticals USA, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2023.
$610K
Total Spend
3
Years Active
1
Firms Hired
7
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $290K |
| 2022 | $320K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Copyright/Patent
- •Discussions involving genetic medicines.
- •Discussions regarding the approval of generic drugs
- •Monitored HR 1868, To prevent across-the-board direct spending cuts, and for other purposes
- •Monitored Medicare and prescription drug changes
- •Discussions regarding the approval of generic drugs
- •HR 2853 BLOCKING Act of 2021 (all sections of full text)
- •Monitored PL 117-7 To prevent across-the-board direct spending cuts, and for other purpos
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.